CybeRelease: (OTC: APPI) to Use Higher Yielding Production Process

(CybeRelease, January 12, 2007) - Lake Harmony, PA - Advanced Plant Pharmaceuticals, Inc. (OTC BB: APPI) and World Health Energy, Inc. announced that the company will be utilizing a more efficient biodiesel process known as ultrasonication. The higher yielding process will provide the company with production cost advantages.

Currently, biodiesel is produced primarily in batch reactors where required energy is provided by heating and mechanical mixing. However, ultrasonic processing is a more effective process to attain the required mixing while providing the necessary activation energy. Through the use of ultrasonication, a biodiesel yield in excess of 99% can be achieved in a remarkably short time duration of less than 5 minutes in comparison to one hour or more using conventional batch reactor systems. World Health Energy will utilize ultrasonication to benefit from the enhanced efficiency and superior end product quality compared to the standard batch reactors process.

Ultrasonic extraction can greatly accelerate extraction processes. Using an ultrasonic reactor, ultrasonic waves are used to create cavitation bubbles in a solvent material. When these bubbles collapse near the cell walls, it creates shock waves and liquid jets that cause those cells’ walls to break and release their contents into the solvent. The solvent is processed into biodiesel.

the company is working towards the most immediate goal of closing on the $1.2 million financing previously announced for the construction of two bio-diesel plants slated for Kentucky and Florida. Upon closing on the financing, the company will provide details on the construction of the first biodiesel plant.

An 8-K for the merger with World Health Energy will be filed after the satisfaction of the closing conditions, which include, without limitation, issuance and receipt of all consideration relating to the transaction and other customary closing conditions.

To be added to APPI’s corporate e-mail list for shareholders and interested investors, please send an e-mail to ir@advancedplantpharm.com.

To read the complete release, go to http://biz.yahoo.com/pz/070112/111818.html

For a Free Newsletter and more information, go to http://www.OTCReporter.com

CybeRelease Gainers are Amgen Inc. (Nasdaq: AMGN), AsiaInfo Holdings, Inc. (Nasdaq: ASIA), Infosys Technologies Limited (Nasdaq: INFY), Intuit Inc. (Nasdaq: INTU), PHAZAR CORP (Nasdaq: ANTP), Syntel, Inc. (Nasdaq: SYNT), Vertex Pharmaceuticals IIncorporated (Nasdaq: VRTX) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN).

CybeRelease Decliners are Symantec Corporation (Nasdaq: SYMC), Avanex Corporation (Nasdaq: AVNX), Netflix, Inc. (Nasdaq: NFLX), Digital River, Inc. (Nasdaq: DRIV), TiVo Inc. (Nasdaq: TIVO), SunPower Corporation (Nasdaq: SPWR), PW Eagle Inc. (Nasdaq: PWEI) and DayStar Technologies, Inc. (Nasdaq: DSTI).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail